Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Acute Coronary Syndrome V: Nursing Management

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026

Same author

Methodology Misrepresented: Correcting the Record on the American Thoracic Society Community-acquired Pneumonia Guideline Process.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Association of Pulse Dose Corticosteroids With Outcomes Among Patients With Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

CHEST pulmonary·2026

Same author

Practice Patterns of Pulse Dose Corticosteroid Use for Patients Hospitalized With Acute Exacerbations of Idiopathic Pulmonary Fibrosis in the United States.

CHEST pulmonary·2025

Same author

GRADE Guidance 44: strategies to enhance the utilization of randomized and non-randomized studies in evidence syntheses of health interventions.

Journal of clinical epidemiology·2025

Same author

Expert Perspectives on Next Generation Health Guidelines: How to Integrate RWE in EBM.

Pragmatic and observational research·2025

Search research articles

Related Experiment Video

Updated: Nov 16, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

Coronavirus disease 2019 management.

Kevin C Wilson¹

¹Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.

Current Opinion in Pulmonary Medicine

|February 19, 2021

Summary

This summary is machine-generated.

Remdesivir and dexamethasone are effective COVID-19 treatments. Remdesivir benefits less severe cases, while dexamethasone helps severe cases, guiding optimal therapeutic strategies for coronavirus disease 2019.

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

Related Experiment Videos

Last Updated: Nov 16, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

Area of Science:

Infectious Diseases
Critical Care Medicine
Pharmacology

Background:

Coronavirus disease 2019 (COVID-19) is a severe multisystem illness caused by SARS-CoV-2.
Effective therapeutic strategies for COVID-19 are crucial for patient management.
Clinical approaches to COVID-19 treatment are continuously evolving based on emerging evidence.

Purpose of the Study:

To review current evidence on effective therapeutics for COVID-19.
To provide guidance on the optimal use of remdesivir and dexamethasone.
To highlight the evolving landscape of COVID-19 treatment.

Main Methods:

Review of randomized controlled trials and subgroup analyses for COVID-19 therapeutics.
Evaluation of evidence for remdesivir and dexamethasone efficacy.
Synthesis of findings to inform clinical recommendations.

Main Results:

Remdesivir and dexamethasone are the first COVID-19 therapeutics with evidence of efficacy from randomized trials.
Remdesivir shows benefit in hospitalized patients with less severe illness.
Dexamethasone is more beneficial in hospitalized patients with severe illness.

Conclusions:

Hospitalized patients requiring supplemental oxygen but not mechanical ventilation should receive both remdesivir and dexamethasone.
Hospitalized patients requiring mechanical ventilation should receive dexamethasone monotherapy.
Ongoing research into other therapies like anti-SARS-CoV-2 antibodies and anti-interleukin agents is critical.